Find clinical trials for Pancreatic Cancer in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma

Cancer

Carcinoma

Colorectal Cancer

Non-Small-Cell Lung Carcinoma

Lung Cancer

Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Warszawa, Mazowieckie, POL:

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

activity in participants with advanced metastatic colorectal cancer, ovarian cancer, renal cancer or pancreatic c....

Enrolling

Metastatic Pancreatic Carcinoma

Advanced Pancreatic Carcinoma

Drug: OATD-02

Phase 1

Molecure

Warsaw, Mazowieckie, Poland and 2 other locations

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...

Enrolling

Gastroesophageal Junction Cancer

Gastric Cancer

Drug: l-leucovorin

Drug: Gemcitabine

Phase 2

AstraZeneca

Warszawa, Poland and 48 other locations

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (PETRA)

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age...

Enrolling

Breast Cancer

Biliary Cancer

Drug: Camizestrant

Drug: T- Dxd

Phase 1, Phase 2

AstraZeneca

Warszawa, Poland and 73 other locations

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

The purpose of this study is to provide continued supply of ruxolitinib alone, ruxolitinib plus background cancer therapy, or background cancer...

Active, not recruiting

Breast Cancer

Colorectal Cancer (CRC)

Drug: Regorafenib

Drug: Capecitabine

Phase 2

Incyte

Warszawa, Poland and 8 other locations

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of escalating doses of RMC-6291 (KRAS G12C(ON) inhibitor...

Active, not recruiting

Colorectal Cancer (CRC)

Non-Small Cell Lung Cancer (NSCLC)

Drug: RMC-6291

Phase 1

Revolution Medicines

Warsaw, Poland and 63 other locations

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor...

Active, not recruiting

Breast Cancer

Papillary Thyroid Cancer

Drug: Entrectinib

Phase 2

Roche

Warszawa, Poland and 122 other locations

A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors (DPT02)

consist of Part 1 which includes 7 cohorts of: urothelial bladder cancer, biliary tract cancer, cervical cancer, endometri ...

Enrolling

Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer

Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer

Drug: Trastuzumab deruxtecan

Phase 2

AstraZeneca

Warszawa, Poland and 116 other locations

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

and nab-paclitaxel, for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery ...

Active, not recruiting

Pancreas Adenocarcinoma

Drug: Gemcitabine

Drug: nab paclitaxel

Phase 3

NovoCure

Warsaw, Poland and 197 other locations

Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers

AFM24-102 is a Phase 1/2a open-label, non-randomized, multicenter, dose escalation, and expansion study evaluating AFM24 in combination with atezoliz...

Enrolling

Advanced Solid Tumor

Drug: AFM24

Drug: Atezolizumab 840 MG in 14 ML Injection

Phase 1, Phase 2

Affimed

Warsaw, Poland and 15 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Pancreatic Cancer in .css-epvm6{white-space:nowrap;}Warszawa, Mazowieckie

Related conditions:

Pancreatic Cancer trials near Warszawa, Mazowieckie, POL:

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (PETRA)

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)

A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors (DPT02)

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers

Find clinical trials for Pancreatic Cancer in Warszawa, Mazowieckie